{"id":"W4414780017","doi":"10.1080/10428194.2025.2561117","title":"Subcutaneous daratumumab plus carfilzomib and dexamethasone (D-Kd) versus carfilzomib and dexamethasone (Kd) in patients with relapsed/refractory multiple myeloma who received previous daratumumab treatment: LYNX study","year":2025,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hotel Dieu Hospital; Institute of Cancer Research; University of Calgary","funders":"","keywords":"Daratumumab; Carfilzomib; Dexamethasone; Multiple myeloma; Clinical endpoint; Interim analysis; Panobinostat; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002345235,0.0007079229,0.002078469,0.0002541329,0.000243554,0.0008465568,0.0004697796,0.0007977335,0.002467644],"category_scores_gemma":[0.001650281,0.0003541607,0.002343122,0.0002699397,0.0006272215,0.0007195823,0.0003046519,0.002247228,0.0004351373],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006024988,"about_ca_system_score_gemma":0.0007704191,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006341427,"about_ca_topic_score_gemma":0.001643357,"domain_scores_codex":[0.9993023,0.0004372204,0.00004589717,0.00007997764,0.00006665986,0.00006791305],"domain_scores_gemma":[0.9988735,0.0003890274,0.00023861,0.00008559899,0.00005120238,0.0003619493],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9277722,0.009756192,0.004151478,0.00053394,0.002302124,0.00007371997,0.0001252532,0.0006055395,0.004408045,0.0001032609,0.0006875246,0.04948076],"study_design_scores_gemma":[0.6421221,0.3343932,0.01741479,0.00008420611,0.001880062,0.0001470168,0.00006276614,0.001337288,0.0008972012,0.0001764639,0.001460388,0.00002446031],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942117,0.003769397,0.0001786074,0.0004025367,0.0001711254,0.0003936635,0.0001973447,0.00002235262,0.0006531174],"genre_scores_gemma":[0.9954914,0.001978751,0.0003763121,0.0004816809,0.0003047618,0.0002832839,0.0003385101,0.000006169346,0.0007391167],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002467644,"threshold_uncertainty_score":0.01240295,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01330566465056755,"score_gpt":0.2623590808136319,"score_spread":0.2490534161630643,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}